Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally
Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally
Before sunrise on MLK Day, more than 50 BioBridge Global staff members gathered in downtown San Antonio to take part in the city’s annual MLK
Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally
Potency assays are a cornerstone of effective cell therapies, but they can also be a source of delay during development. We spoke with Scott Jones,
Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally
Medicare’s New Math on CAR-T Reimbursement Changes: Who Wins, Who Hurts, and What Could Break For a decade, CAR-T has been the ultimate “no-brainer” innovation
Picture a corridor lined with doors: blood cancers, solid tumors, autoimmune, genetic, and rare diseases, all opening wider at once. The field is no longer
Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally
The FDA’s fall initiatives mark an inflection point for gene and cell therapy development—introducing policy shifts that go far beyond the usual cycle of headline-grabbing
Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally
Master Control 2025 Summit Keynote – Prepared for web publication Opening Please welcome Emmanuel Casa Sola of BioBridge Global. Every second counts. In the time